Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Diagnosis & Disease Information
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Minority Patients Remain Underrepresented in Clinical Trials of Pancreatic Cancer
Non-White and non-Hispanic patients were underrepresented throughout the period studied.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
- Loading...
Loading...
Next post in News
Loading... 
Loading...